MED12 mutation frequency in unselected sporadic uterine leiomyomas

Objective: To determine the frequency of mediator complex subunit 12 (MED12) mutations in well-documented, prospectively collected, unselected series of sporadic uterine leiomyomas to better understand the contribution of MED12 mutations in leiomyoma genesis. Design: Mutation analysis of two prospectively collected sample series. Setting: Department of gynecology in university hospital and medical genetics research laboratory. Patient(s): 164 uterine leiomyomas from 28 patients (13 consecutive and 15 unselected patients) undergoing hysterectomy. Intervention(s): MED12 mutation screening by direct sequencing, and clinical data collection. Main Outcome Measure(s): MED12 mutation status and various clinical variables. Result(s): MED12 mutations were found in 73 (83.0%) of 88 and 65 (85.5%) of 76 of uterine leiomyomas from the consecutive and unselected patient series, respectively. Smaller tumor size and a larger number of tumors correlated with positive MED12 mutation status. Conclusion(s): The frequency of MED12 mutations in our prospectively collected uterine leiomyoma sets was higher than in previous works. This is in keeping with the concept that MED12 mutation-positive tumors tend to be smaller in size than MED12 mutation-negative tumors. The results highlight the central role of MED12 mutations in uterine leiomyoma genesis. (C) 2014 by American Society for Reproductive Medicine.